Anthraquinone and anthracene derivatives as inhibitors of the cell-adhesion molecules of the immune system
US5412123A · kind A · utility
43Cited by
2References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 8, 1993 |
| Grant date | May 2, 1995 |
| Priority date | — |
| Expiry date | Feb 8, 2013 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC09B6/00
- WIPO fieldBasic materials chemistry
- WIPO sectorChemistry
Abstract
Derivatives of anthraquinone and anthracene are synthesized and formulated into pharmaceutical formulations. When the formulations are administered the derivatives act as ligands binding to an interrupting the biological chain of events associated with selectin receptors in the human body.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.